Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients: A Prospective Follow-Up Study | Zendy

Ronald Sträter | Zendy; Karin Kurnik | Zendy; Christine Heller | Zendy; R. Schobeß | Zendy; Petra Luigs | Zendy; Ulrike NowakGöttl | Zendy

Open Access

Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients: A Prospective Follow-Up Study

Author(s) -

Ronald Sträter,

Karin Kurnik,

Christine Heller,

R. Schobeß,

Petra Luigs,

Ulrike NowakGöttl

Publication year - 2001

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/hs1101.097379

Subject(s) - medicine , antithrombotic , aspirin , stroke (engine) , low molecular weight heparin , fibrinolytic agent , population , prospective cohort study , anticoagulant , surgery , heparin , mechanical engineering , environmental health , engineering

We sought to compare different antithrombotic secondary treatments (mainly medium-dose aspirin with low-dose low-molecular-weight heparin [LMWH]) in pediatric patients with a first ischemic stroke onset with regard to the risk of stroke recurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research